Executives
?
Phillips Jack
Chief Executive Officer
Accelerate Diagnostics, Inc.
US, Tucson [HQ]
CIK
1784805
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
60,274
Price per Share :
$1.05
Equivalence :
$63,287.70
Transaction History
-
M60,274 Shares After TransactionValue : $n/a$0.0Transaction Date : 12/13/23
-
Footnotes
-
-
Footnotes:#1 The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.#2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
-
S59,535 Shares After TransactionValue : $261,358.65Sold $3,244.21Transaction Date : 12/13/23
-
Footnotes
-
-
Footnotes:#1 The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.#2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
-
M189,654 Shares After TransactionValue : $n/a$0.0Transaction Date : 04/17/24
-
Footnotes
-
-
Footnotes:#1 On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting.#2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
-
S162,919 Shares After TransactionValue : $127,076.82Sold $20,853.30Transaction Date : 04/17/24
-
Footnotes
-
-
Footnotes:#1 On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting.#2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
-
M57,322 Shares After TransactionValue : $n/a$0.0Transaction Date : 09/13/23
-
Footnotes
-
-
Footnotes:#1 The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.#2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.